TERN TERN

Terns Pharmaceuticals Stock Price

4.62
0.00 (0.0%)
4.62
Volume 113
Bid Price 4.13
Ask Price 5.97
News -
Day High

Low
1.45

52 Week Range

High
13.77

Day Low
Company Name Stock Ticker Symbol Market Type
Terns Pharmaceuticals Inc TERN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 4.62 04:55:02
Open Price Low Price High Price Close Price Prev Close
4.62
Trades Volume Avg Volume 52 Week Range
8 113 - 1.45 - 13.77
Last Trade Time Type Quantity Stock Price Currency
04:33:09 28 $ 4.62 USD

Period:

Draw Mode:

Terns Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 117.18M 25.36M 11.31M $ 1,000.00k $ - -2.35 -2.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 518.97k 1.20%

more financials information »

Terns Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TERN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.255.502.253.902,876,1322.37105.33%
1 Month2.425.501.793.77775,6712.2090.91%
3 Months1.545.501.513.20400,3733.08200.0%
6 Months3.565.501.452.99232,8011.0629.78%
1 Year11.1813.771.454.19147,603-6.56-58.68%
3 Years16.9528.361.458.94140,536-12.33-72.74%
5 Years16.9528.361.458.94140,536-12.33-72.74%

Terns Pharmaceuticals Description

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases.


Your Recent History
NASDAQ
TERN
Terns Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now